Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SISTEMI
ChiCTR-IPR-17010501Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of salvianolate in myocardial infarction (MI) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Started Jan 2017; status: recruiting.
02
Drugs
salvianolate
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-IPR-17010501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010501.